Skip to main content

and
  1. No Access

    Article

    Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer

    Development of colorectal cancer (CRC) is regulated by a series of genetic and microenvironmental alterations. Olfactomedin 4 (OLFM4) is a secreted glycoprotein that is highly expressed in the gastrointestinal...

    Hyun Woo Ma, Jung Min Kim, Da Hye Kim, I Seul Park, Ji Hyung Kim in Cancer Gene Therapy (2023)

  2. Article

    Open Access

    PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models

    Cancer cells have developed molecular strategies to cope with evolutionary stressors in the dynamic tumor microenvironment. Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) is a metabolic rh...

    Ki Cheong Park, Jung Min Kim, Sang Yong Kim, Seok-Mo Kim, ** Hong Lim in BMC Medicine (2023)

  3. Article

    Open Access

    VEGF-C induced by TGF- β1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis

    The role of TGF-β1 in lymph node metastasis and lymphangiogenesis, one of the most important steps of gastric cancer dissemination, is largely unknown. The goal of this study was to investigate the role of TGF...

    Kyung Ho Pak, Ki Cheong Park, Jae-Ho Cheong in BMC Cancer (2019)

  4. Article

    Open Access

    SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer

    In the last decade, several tyrosine kinase inhibitors (TKIs), which disrupt pathways involved in the proliferation and tumorigenesis of thyroid cancer, have been extensively studied. Two different TKIs, lenva...

    Soo Young Kim, Seok-Mo Kim, Ho-** Chang, Bup-Woo Kim, Yong Sang Lee in BMC Cancer (2018)

  5. Article

    Open Access

    Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype

    Gastric cancer is a heterogeneous cancer, making treatment responses difficult to predict. Here we show that we identify two distinct molecular subtypes, mesenchymal phenotype (MP) and epithelial phenotype (EP...

    Sang Cheul Oh, Bo Hwa Sohn, Jae-Ho Cheong, Sang-Bae Kim in Nature Communications (2018)

  6. Article

    Open Access

    Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer

    Thyroid cancer has been indicated to have a higher global proportion of DNA methylation and a decreased level of histone acetylation. Previous studies showed that histone gene reviser and epigenetic changes ro...

    Seok-Mo Kim, Ki-Cheong Park, Jeong-Yong Jeon, Bup-Woo Kim, Hyeung-Kyoo Kim in BMC Cancer (2015)

  7. Article

    Open Access

    The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells

    Recent reports using metabolism regulating drugs showed that nutrient deprivation was an efficient tool to suppress cancer progression. In addition, autophagy control is emerging to prevent cancer cell surviva...

    Jeong Yong Jeon, Seung Won Kim, Ki Cheong Park, Mi** Yun in BMC Cancer (2015)

  8. Article

    Open Access

    The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells

    Epigenetic modifications play a critical role in the regulation of all DNA-based processes, such as transcription, repair, and replication. Inappropriate histone modifications can result in dysregulation of ce...

    Ki Cheong Park, Jun Hyeok Heo, Jeong Yong Jeon, Hye Ji Choi, A Ra Jo in BMC Cancer (2015)

  9. No Access

    Article

    Effects of endostatin and a new drug terpestacin against human neuroblastoma xenograft and cell lines

    New development in the vascular network is a significant process for the proliferation, as well as metastatic expand, of cancer cells that depends on a sufficient provider of oxygen and nutrients and the remov...

    Ki Cheong Park, Seung Hoon Choi in Pediatric Surgery International (2013)

  10. No Access

    Article

    Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer

    Although it has been well established that galectin-4 is selectively expressed by intestinal epithelial cells, the role of galectin-4 in colorectal cancer (CRC) development is, as yet, poorly understood. Here,...

    Seung Won Kim, Ki Cheong Park, Soung Min Jeon, Tak Bum Ohn, Tae Il Kim in Cellular Oncology (2013)